Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mark Amir"'
Autor:
Zucker, Roy, Lavie, Gil, Wolff-Sagy, Yael, Gur-Arieh, Noa, Markovits, Hila, Abu-Ahmad, Wiessam, Battat, Erez, Ramot, Noga, Beckenstein, Tanya, Carmeli, Guy, Mark-Amir, Avner, Wagner-Kolasko, Gal, Edry, Amos, Duskin-Bitan, Hadar, Yaron, Shlomit, Peretz, Alon, Hammerman, Ariel, Netzer, Doron, Arbel, Ronen
Publikováno v:
In Clinical Microbiology and Infection August 2023 29(8):1070-1074
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yael Wolff Sagy, Roy Zucker, Ariel Hammerman, Hila Markovits, Noa Gur Arieh, Wiessam Abu Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ronen Arbel, Gil Lavie, Doron Netzer
Publikováno v:
Nature Medicine. 29:748-752
Autor:
Roy Zucker, Gil Lavie, Yael Wolff-Sagy, Noa Gur-Arieh, Hila Markovits, Wiessam Abu-Ahmad, Erez Battat, Noga Ramot, Tanya Beckenstein, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Amos Edry, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ariel Hammerman, Doron Netzer, Ronen Arbel
Publikováno v:
Clinical Microbiology and Infection.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ronen Arbel, Yael Wolff-Sagy, Roy Zucker, Ariel Hammerman, Noa Gur Arieh, Hila Markovits, Wiessam Abu-Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Gil Lavie, Doron Netzer
The recent global outbreak of the human monkeypox virus was declared a public health emergency by the WHO. Modified Vaccinia Ankara (MVA), provided in a two-dose regimen, is currently the only FDA-approved vaccine against monkeypox virus infection (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e272e51e34dc73a3c3cd9a3a51e6dbf
https://doi.org/10.21203/rs.3.rs-2276854/v1
https://doi.org/10.21203/rs.3.rs-2276854/v1
Autor:
Roy Zucker, Gil Lavie, Yael Wolff Sagy, Noa Gur Arieh, Hila Markovits, Weissam Abu-Ahmad, Erez Battat, Noga Ramot, Tanya Beckenstein, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Amos Edry, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Doron Netzer, Ronen Arbel
Background The global supply of vaccines against monkeypox virus infection (MPXVi) is significantly lower than demand. Evidence-based vaccine prioritization criteria, based on risk assessment, are essential for fair vaccine distribution. Our objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40e041333323ef29581550106db5f79f
https://doi.org/10.21203/rs.3.rs-1904714/v2
https://doi.org/10.21203/rs.3.rs-1904714/v2
Autor:
Ronen Arbel, Yael Wolff Sagy, Roy Zucker, Noa Gur Arieh, Hila Markovits, Wiessam Abu-Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ariel Hammerman, Gil Lavie, Doron Netzer
Background The recent global outbreak of the human monkeypox virus (MPXV) was declared a public health emergency by the World Health Organization. Modified Vaccinia Ankara (MVA) is currently the only FDA-approved vaccine against MPXV that was approve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7c88dd4ee7b8b875fdf0ec74192599
https://doi.org/10.21203/rs.3.rs-1976861/v2
https://doi.org/10.21203/rs.3.rs-1976861/v2
Autor:
Ronen Arbel, Yael Wolff Sagy, Roy Zucker, Noa Gur Arieh, Hila Markovits, Wiessam Abu-Ahmad, Erez Battat, Noga Ramot, Guy Carmeli, Avner Mark-Amir, Gal Wagner-Kolasko, Hadar Duskin-Bitan, Shlomit Yaron, Alon Peretz, Ariel Hammerman, Gil Lavie, Doron Netzer
BackgroundThe recent global outbreak of the human monkeypox virus (MPXV) was declared a public health emergency by the World Health Organization. Modified Vaccinia Ankara (MVA) is currently the only FDA-approved vaccine against MPXV that was approved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d577fbd0efcd9449fc2f27227823605
https://doi.org/10.21203/rs.3.rs-1976861/v1
https://doi.org/10.21203/rs.3.rs-1976861/v1
Autor:
Inas Helwa, Randa Mokhtar, Yasmin M. Kolaib, Mafaza Wahba, Nada Alshafei, Mark Amir Iskaros, Shehab El Din Yasser Kandil
Publikováno v:
Journal of Oral Disease Marker. 4:7-13